FDA Investigator Karen Mcnabb Noon
Karen Mcnabb Noon has conducted inspections on 67 sites in 1 countries as of 25 Jun 2007. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
67
Last Inspection Date:
25 Jun 2007
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Karen Mcnabb Noon:
Alan R Condon,
Aldo J Quintana,
Alice C Silva,
Althea A Williams,
Amber G Wardwell,
Amy C Jordan,
Andrew M Barlow,
Anthony N Onianwa,
Ashley M Whitehurst,
Atricia L Irons,
Bradley D Newsad,
Brenda P King,
Camerson E Moore,
Carla C Cummins,
Carla C Tuite,
Carlos Chavez,
Constance Desimone,
Daniel L Zheng,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
Dawn M Braswell,
Dorothy W Lee,
Douglas S Joslin,
Dr. Sriram Subramaniam, PhD,
Edmund F Mrak, Jr,
Elizabeth B Griffin,
Ellen P Madigan,
Emir Galevi,
Gary J Hagan,
George T Allen, Jr,
Gerard D Difiore,
Hugh M Mcclure, II,
James H Tanner,
James P Finn,
James W Whitney,
Jason A Rossi,
John A Sciacchitano,
John L Zaccone,
John P Mistler,
Jonathan B Lewis,
Jonathan G Matrisciano,
Jose A Torres,
Joseph B Cascio,
Joseph C Teixeira,
Joseph H Procopio, Jr,
Joyce A Kellett,
Justine M Corson,
Kalkidan A Molla,
Kenneth H Williams,
Kent A Conforti,
Kristina J Donohue,
Lauren M Lawrance,
Laurie B Frazier,
LCDR Debra Emerson,
Leo B Zadecky,
Leonard H Lavi,
Lorayne A Mcguinness,
Lori M Newman,
Marcia M Laughrey,
Mark E Farrell,
Martin J Guardia,
Matthew C Watson,
Maura Rooney,
Melissa N Gregorio,
Meredith L Miller,
Michael J Casey,
Michael P Anthony,
Michelle M Noe Varga,
Monique C Lo,
Nabil Nakhoul,
Nealie C Newberger,
Pamela L Ogonowski,
Paraluman S Leonin,
Paul A Bonneau,
Paul P Geraci,
Paula M Laplant,
Philip H Lafleur,
Philip Kreiter,
Richard B Mcaroy,
Richard H Penta,
Richard L Licari,
Robert J Martin,
Robert O'brian,
Rory K Geyer,
Rupa Pradhan,
Sandra P White,
Scott B Laufenberg,
Sean R Marcsisin,
Seth A Mailhot,
Shawn M Bogdan,
Sherry M Nisson,
Stacey S Degarmo,
Stephen C Smith,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Teddy Tom,
Thomas Cote,
Thomas J Kelly,
Wendy A Johnecheck
Karen Mcnabb Noon's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2003 | FDA 483 | Cardinal Enterprises Inc. - Form 483, 2003-06-02 |
May, 2006 | FDA 483 | Medelle Corporation - Form 483, 2006-05-12 |
March, 2006 | EIR | Elizabeth L. Hohmann, M.D. - EIR, 2006-03-10 |
December, 2003 | EIR | Egilius Spierings, Md - EIR, 2003-11-20 |
January, 2005 | EIR | Daniel Cohen, MD - EIR, 2005-01-28 |
March, 2006 | FDA 483 | Elizabeth L. Hohmann, M.D. - Form 483, 2006-03-10 |
May, 2003 | FDA 483 | Tomy International Inc. - Form 483, 2003-05-09 |
June, 2003 | FDA 483 | Lantheus Medical Imaging, Inc. - Form 483, 2003-06-24 |
January, 2005 | FDA 483 | Daniel Cohen, MD - Form 483, 2005-01-28 |
March, 2006 | FDA 483 Response | Elizabeth L. Hohmann, M.D. - Form 483R, 2006-03-16 |
June, 2003 | EIR | Lantheus Medical Imaging, Inc. - EIR, 2003-06-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more